The alterations of CUGBP1 activity in DM1 occur due to an increase in active GSK3β kinase, which regulates CUGBP1 phosphorylation at Ser302 through the cyclin D3-CDK4 pathway [9]. Here, GSK3B is linked to myotonic dystrophy type 1.